- Home
- APCX vs KZIA Comparison
APCX vs KZIA Comparison
Compare APCX & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APCX
- KZIA
- Stock Information
- Founded
- APCX 2006
- KZIA 1994
- Country
- APCX United States
- KZIA Australia
- Employees
- APCX N/A
- KZIA N/A
- Industry
- APCX Finance: Consumer Services
- KZIA Biotechnology: Pharmaceutical Preparations
- Sector
- APCX Finance
- KZIA Health Care
- Exchange
- APCX Nasdaq
- KZIA Nasdaq
- Market Cap
- APCX N/A
- KZIA 18.7M
- IPO Year
- APCX N/A
- KZIA 1999
- Fundamental
- Price
- APCX $0.60
- KZIA $3.02
- Analyst Decision
- APCX
- KZIA Strong Buy
- Analyst Count
- APCX 0
- KZIA 1
- Target Price
- APCX N/A
- KZIA $20.00
- AVG Volume (30 Days)
- APCX 10.7M
- KZIA 85.9K
- Earning Date
- APCX 11-14-2024
- KZIA 01-03-2025
- Dividend Yield
- APCX N/A
- KZIA N/A
- EPS Growth
- APCX N/A
- KZIA N/A
- EPS
- APCX N/A
- KZIA N/A
- Revenue
- APCX $365,000.00
- KZIA $1,655,324.00
- Revenue This Year
- APCX $1,315.48
- KZIA $806.89
- Revenue Next Year
- APCX N/A
- KZIA N/A
- P/E Ratio
- APCX N/A
- KZIA N/A
- Revenue Growth
- APCX N/A
- KZIA 248000.00
- 52 Week Low
- APCX $0.31
- KZIA $1.90
- 52 Week High
- APCX $2.30
- KZIA $15.80
- Technical
- Relative Strength Index (RSI)
- APCX 60.21
- KZIA 30.94
- Support Level
- APCX $0.36
- KZIA $2.78
- Resistance Level
- APCX $1.49
- KZIA $4.20
- Average True Range (ATR)
- APCX 0.14
- KZIA 0.55
- MACD
- APCX 0.02
- KZIA -0.13
- Stochastic Oscillator
- APCX 24.32
- KZIA 9.92
About KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors.